Wed, 30 March 2016
Healthcare: Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Merck, Gilead Sciences, and Ionis get a verdict in their patent suit, and Congressmen call for a patent review of Medivation's Xtandi. |